Li Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Li Cai has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
- Ying Li
Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China
7 shared publications Brianna Rodriguez
5 shared publicationsZachary Finkel
5 shared publicationsEvangeline Tzatzalos
Department of Biomedical Engineering, Rutgers University, 599 Taylor Road, Piscataway, NJ 08854, USA
4 shared publicationsHailing Hao
Department of Biomedical Engineering, Rutgers University, Piscataway, New Jersey
4 shared publicationsXin Ai
4 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 10 (2) , e202603861
Label-free multi-metric pipeline for reproducible clustering of single-cell RNA-seq cell types
Single-cell RNA sequencing has transformed our ability to identify cell types and explore cellular diversity. However, determining whether apparent cell subtypes represent true biological populations or artifacts of data analysis remains a major challenge. To address this issue, we developed scClustBench, an open-source benchmarking framework that evaluates cluster quality, stability, and reproducibility across multiple analytical approaches. Rather than relying on a single clustering method, scClustBench tests whether proposed cell subtypes can be consistently recovered. We applied scClustBench to a mouse retinal dataset containing bipolar cells, which are known to exhibit subtype diversity, and rod photoreceptors, for which subtype classification remains controversial. The framework consistently identified reproducible bipolar cell subtypes across analytical methods. In contrast, while some rod photoreceptor clusters appeared stable during resampling analyses, they could not be reproduced across embedding methods, suggesting that these partitions do not represent robust biological subtypes. Additional analyses using simulated and external datasets demonstrated that scClustBench reliably distinguishes meaningful cellular heterogeneity from analytical artifacts. These findings provide a practical framework for rigorous interpretation of single-cell transcriptomic data.
- 16 November 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 10 (2) , e202603861
Open AccessLabel-free multi-metric pipeline for reproducible clustering of single-cell RNA-seq cell types
Single-cell RNA sequencing has transformed our ability to identify cell types and explore cellular diversity. However, determining whether apparent cell subtypes represent true biological populations or artifacts of data analysis remains a major challenge. To address this issue, we developed scClustBench, an open-source benchmarking framework that evaluates cluster quality, stability, and reproducibility across multiple analytical approaches. Rather than relying on a single clustering method, scClustBench tests whether proposed cell subtypes can be consistently recovered. We applied scClustBench to a mouse retinal dataset containing bipolar cells, which are known to exhibit subtype diversity, and rod photoreceptors, for which subtype classification remains controversial. The framework consistently identified reproducible bipolar cell subtypes across analytical methods. In contrast, while some rod photoreceptor clusters appeared stable during resampling analyses, they could not be reproduced across embedding methods, suggesting that these partitions do not represent robust biological subtypes. Additional analyses using simulated and external datasets demonstrated that scClustBench reliably distinguishes meaningful cellular heterogeneity from analytical artifacts. These findings provide a practical framework for rigorous interpretation of single-cell transcriptomic data.
- Open Access
- 9 November 2026
- Published by Elsevier in Molecular Therapy Advances
AAV6-Gsx1 promotes sustained functional recovery in a pilot long-term study after contusion spinal cord injury
- 9 November 2026
- Published by Elsevier in Molecular Therapy Advances
Open AccessAAV6-Gsx1 promotes sustained functional recovery in a pilot long-term study after contusion spinal cord injury
- Open Access
A Label-Free Multi-Metric Pipeline for Benchmarking Single-Cell RNA-Sequencing Clustering and Testing the Reproducibility of Cell-Type Heterogeneity
A discovered sub-population from single-cell transcriptomic data is only meaningful if it is reproducible, yet clustering is usually done with one method on one embedding and rarely tested. We present a label- free, multi-metric pipeline that reframes clustering as an auditable, methods-blind decision and separates two notions of stability that are commonly conflated: reproducibility under cell resampling (bootstrap) and reproducibility under re-embedding (retraining the representation). The pipeline evaluates seven clustering configurations across cluster counts using five non-redundant quality metrics. As a whole- dataset control on a mouse retinal atlas, it recovers an eight-cell-type annotation at 96.3% accuracy (adjusted Rand index, ARI = 0.91) without labels. We then validate the discovery mode on two cell types with opposite ground truth. On bipolar cells, which have well-established subtypes, the pipeline accepts the sub-structure: across-embedding reproducibility rises with cluster number to a high plateau (mean pairwise ARI ∼0.93 near the ∼15 known bipolar subtypes), with quality metrics improving in parallel. On rod photoreceptors, treated as homogeneous, it rejects over-clustering: the metric-selected partition passes a bootstrap-stability check but is not reproducible when the embedding is retrained (mean pairwise ARI = 0.69), and the metrics do not improve with cluster number. On synthetic data, the test recovers real structure down to a 5% subpopulation while rejecting null data (high sensitivity and specificity). Bootstrap stability alone is therefore insufficient evidence for sub-population; the across-embedding test discriminates real sub-structure from over-clustering and applies to any cell type as a reproducible alternative to single-method, single-embedding clustering.
Open AccessA Label-Free Multi-Metric Pipeline for Benchmarking Single-Cell RNA-Sequencing Clustering and Testing the Reproducibility of Cell-Type Heterogeneity
A discovered sub-population from single-cell transcriptomic data is only meaningful if it is reproducible, yet clustering is usually done with one method on one embedding and rarely tested. We present a label- free, multi-metric pipeline that reframes clustering as an auditable, methods-blind decision and separates two notions of stability that are commonly conflated: reproducibility under cell resampling (bootstrap) and reproducibility under re-embedding (retraining the representation). The pipeline evaluates seven clustering configurations across cluster counts using five non-redundant quality metrics. As a whole- dataset control on a mouse retinal atlas, it recovers an eight-cell-type annotation at 96.3% accuracy (adjusted Rand index, ARI = 0.91) without labels. We then validate the discovery mode on two cell types with opposite ground truth. On bipolar cells, which have well-established subtypes, the pipeline accepts the sub-structure: across-embedding reproducibility rises with cluster number to a high plateau (mean pairwise ARI ∼0.93 near the ∼15 known bipolar subtypes), with quality metrics improving in parallel. On rod photoreceptors, treated as homogeneous, it rejects over-clustering: the metric-selected partition passes a bootstrap-stability check but is not reproducible when the embedding is retrained (mean pairwise ARI = 0.69), and the metrics do not improve with cluster number. On synthetic data, the test recovers real structure down to a 5% subpopulation while rejecting null data (high sensitivity and specificity). Bootstrap stability alone is therefore insufficient evidence for sub-population; the across-embedding test discriminates real sub-structure from over-clustering and applies to any cell type as a reproducible alternative to single-method, single-embedding clustering.
- Open Access
Top2b-Regulated Genes and Pathways Linked to Retinal Homeostasis and Degeneration
Retinal homeostasis and degeneration are significant contributors to global vision loss, with retinal health primarily assessed by the count and function of photoreceptor cells, the most abundant cells in the retina. Genomic studies have identified topoisomerase II beta (Top2b), an enzyme that untangles DNA supercoils to facilitate gene expression, as a critical transcriptional regulator for retinal health. This review aims to uncover and categorize genes linked to Top2b that are dynamically expressed during retinal degeneration, revealing shared and overlooked regulatory pathways. RNA sequencing data from wild-type and Top2b knockout mice revealed thousands of differentially expressed genes regulated by Top2b. By cross-referencing these genes with retinal degeneration datasets, including RetNet and the Gene Ontology Browser, we identified 44 Top2b-linked genes associated with retinal degeneration. These genes were grouped into fourteen functional categories: ciliary function and trafficking, metabolism, synaptic transmission, transcription factors and regulation, visual cycle, retinoids, and more. Key genes such as Bbs7, Ubb, Rbp4, Cetn2, Pik3r1, and Crx were explored, and their critical pathways for retinal health were outlined. This comprehensive catalog of 44 Top2b-linked retinal homeostatic genes will serve as a valuable resource for researchers. It provides new insights into the regulatory mechanisms underlying retinal homeostasis, setting the framework for the development of targeted therapeutic approaches and early intervention strategies for preventing photoreceptor loss.
Open AccessTop2b-Regulated Genes and Pathways Linked to Retinal Homeostasis and Degeneration
Retinal homeostasis and degeneration are significant contributors to global vision loss, with retinal health primarily assessed by the count and function of photoreceptor cells, the most abundant cells in the retina. Genomic studies have identified topoisomerase II beta (Top2b), an enzyme that untangles DNA supercoils to facilitate gene expression, as a critical transcriptional regulator for retinal health. This review aims to uncover and categorize genes linked to Top2b that are dynamically expressed during retinal degeneration, revealing shared and overlooked regulatory pathways. RNA sequencing data from wild-type and Top2b knockout mice revealed thousands of differentially expressed genes regulated by Top2b. By cross-referencing these genes with retinal degeneration datasets, including RetNet and the Gene Ontology Browser, we identified 44 Top2b-linked genes associated with retinal degeneration. These genes were grouped into fourteen functional categories: ciliary function and trafficking, metabolism, synaptic transmission, transcription factors and regulation, visual cycle, retinoids, and more. Key genes such as Bbs7, Ubb, Rbp4, Cetn2, Pik3r1, and Crx were explored, and their critical pathways for retinal health were outlined. This comprehensive catalog of 44 Top2b-linked retinal homeostatic genes will serve as a valuable resource for researchers. It provides new insights into the regulatory mechanisms underlying retinal homeostasis, setting the framework for the development of targeted therapeutic approaches and early intervention strategies for preventing photoreceptor loss.
- Open Access
- 14 April 2025
- Published by Open Exploration Publishing in Exploration of biomat-x
- Vol. 2, 101335
Top2b regulates morphological and migratory properties of retinal progenitor cells in vivo and upon transplantable matrix substrates
Aim: This study evaluated the impact of retinal extracellular matrix (ECM) and key biomaterial substrates on the motility of transplantable retinal cells with genomic manipulation, using the therapeutic molecule, Topoisomerase II beta (Top2b), as a model. Methods: Tests first applied in ovo electroporation to examine the effects of a pharmacological Top2b inhibitor (ICRF-193) on progenitor motility and development of embryonic retina. Complementary qRT-PCR tests measured changes in select cadherin molecules in response to treatment. In vitro transfection produced cultured retinal progenitor cell groups with Top2b overexpression and Top2b knockdown. Differences in the adhesion and motility of Top2b altered groups, compared to wildtype cells, were measured upon biomaterial substrates used in emerging transplantation matrixes. Results: Data illustrated significant differences in the number and spacing of retinal ganglion cells when retina was treated with ICRF-193, as well as downregulation of several key cadherin molecules. Cultured retinal progenitors with Top2b knockdown and Top2b overexpression exhibited different expression of chemotactic receptors, adhesion parameters, and modalities of migration upon substrates of laminin, poly-L-lysine, and collagen IV. Significant changes in cell morphology and surface area were also measured compared to wildtype cells. Conclusions: Corroborating in vivo and in vitro data support Top2b as a therapeutic target for retinal progenitor motility but indicate significant differences in the migration of Top2b altered cells upon substrates used in transplantation. These data highlight the therapeutic advantages of bioinspired materials developed to aid the motility of replacement cells with modified genetic expression to improve transplantation outcomes across the nervous system.
- 14 April 2025
- Published by Open Exploration Publishing in Exploration of biomat-x
- Vol. 2, 101335
Open AccessTop2b regulates morphological and migratory properties of retinal progenitor cells in vivo and upon transplantable matrix substrates
Aim: This study evaluated the impact of retinal extracellular matrix (ECM) and key biomaterial substrates on the motility of transplantable retinal cells with genomic manipulation, using the therapeutic molecule, Topoisomerase II beta (Top2b), as a model. Methods: Tests first applied in ovo electroporation to examine the effects of a pharmacological Top2b inhibitor (ICRF-193) on progenitor motility and development of embryonic retina. Complementary qRT-PCR tests measured changes in select cadherin molecules in response to treatment. In vitro transfection produced cultured retinal progenitor cell groups with Top2b overexpression and Top2b knockdown. Differences in the adhesion and motility of Top2b altered groups, compared to wildtype cells, were measured upon biomaterial substrates used in emerging transplantation matrixes. Results: Data illustrated significant differences in the number and spacing of retinal ganglion cells when retina was treated with ICRF-193, as well as downregulation of several key cadherin molecules. Cultured retinal progenitors with Top2b knockdown and Top2b overexpression exhibited different expression of chemotactic receptors, adhesion parameters, and modalities of migration upon substrates of laminin, poly-L-lysine, and collagen IV. Significant changes in cell morphology and surface area were also measured compared to wildtype cells. Conclusions: Corroborating in vivo and in vitro data support Top2b as a therapeutic target for retinal progenitor motility but indicate significant differences in the migration of Top2b altered cells upon substrates used in transplantation. These data highlight the therapeutic advantages of bioinspired materials developed to aid the motility of replacement cells with modified genetic expression to improve transplantation outcomes across the nervous system.
- Open Access
- 24 April 2024
- Published by Elsevier in Neurotherapeutics
- Vol. 21 (4) , e00362
AAV6 mediated Gsx1 expression in neural stem progenitor cells promotes neurogenesis and restores locomotor function after contusion spinal cord injury
- 24 April 2024
- Published by Elsevier in Neurotherapeutics
- Vol. 21 (4) , e00362
Open AccessAAV6 mediated Gsx1 expression in neural stem progenitor cells promotes neurogenesis and restores locomotor function after contusion spinal cord injury
- Open Access
Nucleic acid‐based small molecules as targeted transcription therapeutics for immunoregulation
Transcription therapy is an emerging approach that centers on identifying the factors associated with the malfunctioning gene transcription machinery that causes diseases and controlling them with designer agents. Until now, the primary research focus in therapeutic gene modulation has been on small‐molecule drugs that target epigenetic enzymes and critical signaling pathways. However, nucleic acid‐based small molecules have gained popularity in recent years for their amenability to be pre‐designed and realize operative control over the dynamic transcription machinery that governs how the immune system responds to diseases. Pyrrole–imidazole polyamides (PIPs) are well‐established DNA‐based small‐molecule gene regulators that overcome the limitations of their conventional counterparts owing to their sequence‐targeted specificity, versatile regulatory efficiency, and biocompatibility. Here, we emphasize the rational design of PIPs, their functional mechanisms, and their potential as targeted transcription therapeutics for disease treatment by regulating the immune response. Furthermore, we also discuss the challenges and foresight of this approach in personalized immunotherapy in precision medicine.
Open AccessNucleic acid‐based small molecules as targeted transcription therapeutics for immunoregulation
Transcription therapy is an emerging approach that centers on identifying the factors associated with the malfunctioning gene transcription machinery that causes diseases and controlling them with designer agents. Until now, the primary research focus in therapeutic gene modulation has been on small‐molecule drugs that target epigenetic enzymes and critical signaling pathways. However, nucleic acid‐based small molecules have gained popularity in recent years for their amenability to be pre‐designed and realize operative control over the dynamic transcription machinery that governs how the immune system responds to diseases. Pyrrole–imidazole polyamides (PIPs) are well‐established DNA‐based small‐molecule gene regulators that overcome the limitations of their conventional counterparts owing to their sequence‐targeted specificity, versatile regulatory efficiency, and biocompatibility. Here, we emphasize the rational design of PIPs, their functional mechanisms, and their potential as targeted transcription therapeutics for disease treatment by regulating the immune response. Furthermore, we also discuss the challenges and foresight of this approach in personalized immunotherapy in precision medicine.
- Top Cited PapersOpen Access
Current Advancements in Spinal Cord Injury Research—Glial Scar Formation and Neural Regeneration
Spinal cord injury (SCI) is a complex tissue injury resulting in permanent and degenerating damage to the central nervous system (CNS). Detrimental cellular processes occur after SCI, including axonal degeneration, neuronal loss, neuroinflammation, reactive gliosis, and scar formation. The glial scar border forms to segregate the neural lesion and isolate spreading inflammation, reactive oxygen species, and excitotoxicity at the injury epicenter to preserve surrounding healthy tissue. The scar border is a physicochemical barrier composed of elongated astrocytes, fibroblasts, and microglia secreting chondroitin sulfate proteoglycans, collogen, and the dense extra-cellular matrix. While this physiological response preserves viable neural tissue, it is also detrimental to regeneration. To overcome negative outcomes associated with scar formation, therapeutic strategies have been developed: the prevention of scar formation, the resolution of the developed scar, cell transplantation into the lesion, and endogenous cell reprogramming. This review focuses on cellular/molecular aspects of glial scar formation, and discusses advantages and disadvantages of strategies to promote regeneration after SCI.
Top Cited PapersOpen AccessCurrent Advancements in Spinal Cord Injury Research—Glial Scar Formation and Neural Regeneration
Spinal cord injury (SCI) is a complex tissue injury resulting in permanent and degenerating damage to the central nervous system (CNS). Detrimental cellular processes occur after SCI, including axonal degeneration, neuronal loss, neuroinflammation, reactive gliosis, and scar formation. The glial scar border forms to segregate the neural lesion and isolate spreading inflammation, reactive oxygen species, and excitotoxicity at the injury epicenter to preserve surrounding healthy tissue. The scar border is a physicochemical barrier composed of elongated astrocytes, fibroblasts, and microglia secreting chondroitin sulfate proteoglycans, collogen, and the dense extra-cellular matrix. While this physiological response preserves viable neural tissue, it is also detrimental to regeneration. To overcome negative outcomes associated with scar formation, therapeutic strategies have been developed: the prevention of scar formation, the resolution of the developed scar, cell transplantation into the lesion, and endogenous cell reprogramming. This review focuses on cellular/molecular aspects of glial scar formation, and discusses advantages and disadvantages of strategies to promote regeneration after SCI.
- Open Access
- 1 January 2023
- Published by Association for Computational Linguistics (ACL)
- p. 7189-7198
Prediction and Calibration: Complex Reasoning over Knowledge Graph with Bi-directional Directed Acyclic Graph Neural Network
Yao Xu, Shizhu He, Li Cai, Kang Liu, Jun Zhao. Findings of the Association for Computational Linguistics: ACL 2023. 2023.
- 1 January 2023
- Published by Association for Computational Linguistics (ACL)
- p. 7189-7198
Open AccessPrediction and Calibration: Complex Reasoning over Knowledge Graph with Bi-directional Directed Acyclic Graph Neural Network
Yao Xu, Shizhu He, Li Cai, Kang Liu, Jun Zhao. Findings of the Association for Computational Linguistics: ACL 2023. 2023.
- 25 February 2022
- Published by Springer Nature in Eye
- Vol. 36 (7) , 1342-1343
A newly anticipated role for Laptm4b in retinal outer segment development
- 25 February 2022
- Published by Springer Nature in Eye
- Vol. 36 (7) , 1342-1343
A newly anticipated role for Laptm4b in retinal outer segment development